FRIEDBERG, Germany and BAYERN, Germany, May 04, 2020 (GLOBE NEWSWIRE) -- Advanced BioInformatics GmbH, a medical technology company developing solutions that improve long-term outcomes for people with ...
The FDA has started testing the precisionFDA platform it developed with DNAnexus. The closed beta test phase is the precursor to a more widespread rollout of the system, which the CEO of DNAnexus has ...
A free open-access webinar will introduce the Cancer Genome Interpreter (CGI), an advanced bioinformatics tool to interpret mutations in cancer genomes developed by IRB Barcelona and co-created with ...
Bioinformatics underpins and enables research across the life sciences. Thus should we encounter, for the very first time, a pocket watch, we would likely take it apart and investigate its parts – not ...
Immunotherapy is being hailed as the future of cancer treatment. Harnessing the body’s own immune system to attack and kill cancer cells, immunotherapy is a burgeoning field of medicine that offers a ...
Research collaboration: Queensland Facility for Advanced Bioinformatics (QFAB) is a research collaboration whose article contributions are accrued to its participating partner institutions. Represents ...
Exiqon A/S has announced the extension of the miRCURY™ LNA microRNA PCR product line with the launch of a novel bioinformatics software for the design of custom qPCR assays for microRNA quantification ...
Austin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Bioinformatics Market Size Analysis: “According to SNS Insider, The Bioinformatics Market Size was valued at USD 11.45 billion in 2023 and is projected to ...
VEDBAEK, Denmark, Oct. 12, 2010 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ), a leading supplier of high-value gene expression analysis products, today announced the extension of the miRCURY LNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results